{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:05:56Z","timestamp":1784289956938,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002412","name":"Xi'an Jiaotong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031935","name":"Xi'an Jiaotong University","doi-asserted-by":"publisher","award":["2025IIT-M06"],"award-info":[{"award-number":["2025IIT-M06"]}],"id":[{"id":"10.13039\/100031935","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaad.2026.04.020","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:15:05Z","timestamp":1778271305000},"page":"458-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral dapsone in refractory rosacea: A prospective exploratory study defining a \u201chigh inflammatory burden\u201d subtype and a testable precision treatment hypothesis"],"prefix":"10.1016","volume":"95","author":[{"given":"Bingyang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3984-0128","authenticated-orcid":false,"given":"Jiawen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaad.2026.04.020_bib1","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/bjd.15155","article-title":"DOMINO, doxycycline 40 mg vs. minocycline 100 mg in the treatment of rosacea: a randomized, single-blinded, noninferiority trial, comparing efficacy and safety","volume":"176","author":"van der Linden","year":"2017","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.04.020_bib2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/120347541201600615","article-title":"Isotretinoin for the treatment of granulomatous rosacea: case report and review of the literature","volume":"16","author":"Rallis","year":"2012","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.jaad.2026.04.020_bib3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40257-024-00879-8","article-title":"Dapsone use in dermatology","volume":"25","author":"Lovell","year":"2024","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.04.020_bib4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1378\/chest.10-2908","article-title":"Dapsone inhibits IL-8 secretion from human bronchial epithelial cells stimulated with lipopolysaccharide and resolves airway inflammation in the ferret","volume":"140","author":"Kanoh","year":"2011","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jaad.2026.04.020_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0006-2952(92)90449-S","article-title":"Inhibition of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase by dapsone","volume":"44","author":"Bozeman","year":"1992","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.jaad.2026.04.020_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/15569527.2024.2424932","article-title":"The treatment efficacy of 7.5% dapsone gel in papulopustular rosacea: a prospective study","volume":"43","author":"\u00d6zkoca","year":"2024","journal-title":"Cutan Ocul Toxicol"},{"issue":"1","key":"10.1016\/j.jaad.2026.04.020_bib7","article-title":"Efficacy of topical dapsone 5% gel for the treatment of erythematotelangiectatic rosacea: new treatment option with old drug","volume":"14","author":"G\u00f6k\u015fin","year":"2024","journal-title":"Dermatol Pract Concept"},{"issue":"5","key":"10.1016\/j.jaad.2026.04.020_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.70212","article-title":"Comparison of topical 20% azelaic acid and 7.5% dapsone in the treatment of mild-to-moderate papulopustular rosacea","volume":"24","author":"Hasanbeyzade","year":"2025","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2026.04.020_bib9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Del Rosso","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.04.020_bib10","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jaad.2020.01.077","article-title":"Standard management options for rosacea: the 2019 update by the National Rosacea Society Expert Committee","volume":"82","author":"Thiboutot","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.04.020_bib11","article-title":"Interventions for rosacea","volume":"2015","author":"van Zuuren","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.jaad.2026.04.020_bib12","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/archderm.139.11.1444","article-title":"A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial","volume":"139","author":"Elewski","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.04.020_bib13","first-page":"54","article-title":"A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea","volume":"96","author":"Draelos","year":"2015","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2026.04.020_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1169916","article-title":"Efficacy and safety of antibiotic agents in the treatment of rosacea: a systemic network meta-analysis","volume":"14","author":"Xiao","year":"2023","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.jaad.2026.04.020_bib15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/jdv.20315","article-title":"Low-dose isotretinoin for the management of rosacea: a systematic review and meta-analysis","volume":"39","author":"King","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2026.04.020_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.12788\/cutis.1240","article-title":"The skin microbiome in Rosacea: mechanisms, gut-skin interactions, and therapeutic implications","volume":"116","author":"Asees","year":"2025","journal-title":"Cutis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226005578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226005578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:39:23Z","timestamp":1784288363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226005578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0190962226005578"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.04.020","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral dapsone in refractory rosacea: A prospective exploratory study defining a \u201chigh inflammatory burden\u201d subtype and a testable precision treatment hypothesis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}